We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$45.4B
AUM Growth
+$767M
(+1.7%)
Cap. Flow
-$656M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
941
New
55
Increased
254
Reduced
363
Closed
43
Avg Time Held
20.7
quarters
Top 10 Avg Time Held
9.8
quarters
Top 20 Avg Time Held
12.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$138M |
| 2 |
Skyworks Solutions
SWKS
|
+$134M |
| 3 |
Stifel
SF
|
+$116M |
| 4 |
Capri Holdings
CPRI
|
+$97.6M |
| 5 |
Comcast
CMCSA
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$281M |
| 2 |
J.M. Smucker
SJM
|
+$152M |
| 3 |
TRTN
Triton International Limited
TRTN
|
+$139M |
| 4 |
Seagate
STX
|
+$107M |
| 5 |
Pfizer
PFE
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.69% |
| 2 | Healthcare | 15.44% |
| 3 | Technology | 15.26% |
| 4 | Consumer Discretionary | 13.94% |
| 5 | Industrials | 11.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Merck
MRK
$358B
| $980M | 2.16% |
8,495,450
-681,670
| -7% | -$77.4M |
2013 Q2
40 quarters
|
|
2
ExxonMobil
XOM
$707B
| $643M | 1.42% |
5,993,697
-397,370
| -6% | -$43.4M |
2013 Q2
40 quarters
|
|
3
Cisco
CSCO
$454B
| $603M | 1.33% |
11,659,735
+580,820
| +5% | +$28.6M |
2013 Q2
40 quarters
|
|
4
Bristol-Myers Squibb
BMY
$117B
| $601M | 1.33% |
9,398,655
-2,781
| -0% | -$186K |
2018 Q2
20 quarters
|
|
|
5
Comcast
CMCSA
$73B
| $600M | 1.32% |
14,433,200
+2,448,459
| +20% | +$97.2M |
2013 Q2
40 quarters
|
|
|
6
Pfizer
PFE
$162B
| $535M | 1.18% |
14,593,768
-2,693,950
| -16% | -$105M |
2013 Q2
40 quarters
|
|
7
Verizon
VZ
$177B
| $528M | 1.16% |
14,205,207
-378,900
| -3% | -$14M |
2013 Q2
40 quarters
|
|
8
Gilead Sciences
GILD
$186B
| $485M | 1.07% |
6,292,469
-192,260
| -3% | -$15.3M |
2014 Q2
36 quarters
|
|
9
Kroger
KR
$36.6B
| $470M | 1.04% |
9,991,372
-201,140
| -2% | -$9.59M |
2013 Q2
40 quarters
|
|
10
AT&T
T
$154B
| $460M | 1.01% |
28,842,643
-605,700
| -2% | -$10.3M |
2013 Q2
40 quarters
|
|
11
Molson Coors Class B
TAP
$7.09B
| $460M | 1.01% |
6,982,562
-410,800
| -6% | -$25.4M |
2018 Q1
21 quarters
|
|
12
Amgen
AMGN
$224B
| $451M | 0.99% |
2,031,018
-84,300
| -4% | -$19.6M |
2013 Q2
40 quarters
|
|
13
AGCO
AGCO
$7.24B
| $436M | 0.96% |
3,318,770
+140,652
| +4% | +$17.4M |
2013 Q2
40 quarters
|
|
14
Jabil
JBL
$32.5B
| $435M | 0.96% |
4,026,017
+221,458
| +6% | +$19.5M |
2013 Q2
40 quarters
|
|
15
Oracle
ORCL
$416B
| $433M | 0.95% |
3,633,088
-202,652
| -5% | -$21M |
2013 Q2
40 quarters
|
|
16
Ameriprise Financial
AMP
$44.4B
| $422M | 0.93% |
1,271,193
-21,850
| -2% | -$6.72M |
2013 Q2
40 quarters
|
|
17
Meta Platforms (Facebook)
META
$1.9T
| $411M | 0.91% |
1,433,220
-36,690
| -2% | -$9.05M |
2014 Q4
34 quarters
|
|
18
McKesson
MCK
$110B
| $409M | 0.9% |
957,667
-61,277
| -6% | -$23.6M |
2016 Q4
26 quarters
|
|
19
CVS Health
CVS
$112B
| $399M | 0.88% |
5,769,291
+24,247
| +0.4% | +$1.73M |
2013 Q2
40 quarters
|
|
20
HP
HPQ
$26.8B
| $394M | 0.87% |
12,844,710
-358,960
| -3% | -$10.8M |
2013 Q2
40 quarters
|
|
21
Cummins
CMI
$73B
| $389M | 0.86% |
1,586,671
-32,710
| -2% | -$7.41M |
2014 Q3
35 quarters
|
|
22
FedEx
FDX
$68.7B
| $377M | 0.83% |
1,521,580
+15,480
| +1% | +$3.54M |
2013 Q2
40 quarters
|
|
23
Arrow Electronics
ARW
$11.5B
| $375M | 0.83% |
2,619,944
-56,874
| -2% | -$7.08M |
2013 Q2
40 quarters
|
|
24
Citigroup
C
$220B
| $361M | 0.8% |
7,851,721
-152,630
| -2% | -$7.15M |
2013 Q2
40 quarters
|
|
25
Aflac
AFL
$58.2B
| $356M | 0.78% |
5,095,034
-304,360
| -6% | -$20.4M |
2013 Q2
40 quarters
|
|
Similar funds
HF
LSV Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, LSV Asset Management held 941 positions worth $45.4B, up 1.7% from $44.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
LSV Asset Management's Q2 2023 filing shows 55 new, 254 increased, 363 reduced and 43 closed positions. Its largest new stake was Global Payments: 464,480 shares worth $45.8M. The largest sale was Intel, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- LSV Asset Management's largest Q2 2023 buy was Global Payments: 464,480 shares worth $45.8M.
- LSV Asset Management added most to Centene in Q2 2023, an estimated $138M increase.
- LSV Asset Management's biggest Q2 2023 reduction was Intel, cutting an estimated $281M.
- LSV Asset Management fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $40.6M.
- LSV Asset Management's ten largest holdings make up 13% of its $45.4B portfolio in Q2 2023.
- LSV Asset Management opened 55 new positions and closed 43 in Q2 2023.
- LSV Asset Management's portfolio value rose 1.7% quarter-over-quarter to $45.4B.
Based on LSV Asset Management's 13F filing for Q2 2023, filed 2 Aug 2023.